LYN-1604 dihydrochloride|cas:2310109-38-5|西域试剂

LYN-1604 dihydrochloride,99.64%

产品编号：Bellancom-101923B| CAS NO：2310109-38-5| 分子式：C₃₃H₄₅Cl₄N₃O₂| 分子量：657.54

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	价格	库存与货期
Bellancom-101923B	￥1450.00	杭州北京（现货）
Bellancom-101923B	￥2550.00	杭州北京（现货）
Bellancom-101923B	￥4500.00	杭州北京（现货）
Bellancom-101923B	￥7500.00	杭州北京（现货）
Bellancom-101923B	￥11500.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

LYN-1604 dihydrochloride

产品介绍

LYN-1604 dihydrochloride 是一种有效的 UNC-51 样激酶 1 (ULK1) 激活剂，EC₅₀ 值为 18.94 nM。LYN-1604 可用于三阴性乳腺癌 (TNBC) 的研究。

生物活性

LYN-1604 dihydrochloride is a potent UNC-51-like kinase 1 (ULK1) activator (EC₅₀=18.94 nM) for the research of triple negative breast cancer (TNBC).

体外研究

LYN-1604 is a potential ULK1 agonist (enzymatic activity=195.7% at 100 nM and IC₅₀=1.66 μM against MDA-MB-231 cells) .
LYN-1604 binds to wild-type ULK1 with a binding affinity in the nanomole range (K_D=291.4 nM) .
LYN-1604 (0.5, 1.0 and 2.0 μM) induces cell death via the ULK complex in MDA-MB-231 cells.
LYN-1604 (0.5-2 μM, 24 hours) induces remarkable up-regulation of Beclin-1 and degradation of p62, as well as transformation of LC3-I to LC3-II in MDA-MB-231 cells.
LYN-1604 induces ATG5-dependent autophagy via the ULK complex.
LYN-1604 can also increase cleavage of caspase3 and induce apoptosis.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay

Cell Line:	MDA-MB-231 cells
Concentration:	0.5, 1.0 and 2.0 μM
Incubation Time:
Result:	Induced cell death. Autophagy ratio was increased in a dose-dependent manner.

Western Blot Analysis

Cell Line:	MDA-MB-231 cells
Concentration:	0, 0.5, 1, and 2 μM
Incubation Time:	24 hours
Result:	Induced remarkable up-regulation of Beclin-1 and degradation of p62, as well as transformation of LC3-I to LC3-II.

体内研究
(In Vivo)

LYN-1604 (low dose, 25 mg/kg; median dose, 50 mg/kg; high dose, 100 mg/kg; intragastric administration once a day for 14 days) inhibits the growth of xenograft TNBC by targeting ULK1-modulated cell death.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	24 female nude mice (BALB/c, 6-8 weeks, 20-22 g)
Dosage:	Low dose, 25 mg/kg; median dose, 50 mg/kg; high dose, 100 mg/kg
Administration:	Intragastric administration; once a day for 14 days
Result:	Significantly inhibited the growth of xenograft MDA-MB-231 cells. The body weights of mice were stable. By the end of the experiment, the liver and spleen weight indexes of mice were slightly increased in parts of the groups, while the kidney weight index was not affected in all dose groups.

体内研究

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	24 female nude mice (BALB/c, 6-8 weeks, 20-22 g)
Dosage:	Low dose, 25 mg/kg; median dose, 50 mg/kg; high dose, 100 mg/kg
Administration:	Intragastric administration; once a day for 14 days
Result:	Significantly inhibited the growth of xenograft MDA-MB-231 cells. The body weights of mice were stable. By the end of the experiment, the liver and spleen weight indexes of mice were slightly increased in parts of the groups, while the kidney weight index was not affected in all dose groups.

体内研究

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	24 female nude mice (BALB/c, 6-8 weeks, 20-22 g)
Dosage:	Low dose, 25 mg/kg; median dose, 50 mg/kg; high dose, 100 mg/kg
Administration:	Intragastric administration; once a day for 14 days
Result:	Significantly inhibited the growth of xenograft MDA-MB-231 cells. The body weights of mice were stable. By the end of the experiment, the liver and spleen weight indexes of mice were slightly increased in parts of the groups, while the kidney weight index was not affected in all dose groups.

性状

Solid

溶解性数据

In Vitro:

H₂O : 50 mg/mL (76.04 mM; Need ultrasonic)

DMSO : 50 mg/mL (76.04 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	1.5208 mL	7.6041 mL	15.2082 mL
5 mM	0.3042 mL	1.5208 mL	3.0416 mL
10 mM	0.1521 mL	0.7604 mL	1.5208 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用；以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline
Solubility: ≥ 2.5 mg/mL (3.80 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (3.80 mM，饱和度未知) 的澄清溶液。
以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。
将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% corn oil
Solubility: ≥ 2.5 mg/mL (3.80 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (3.80 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。
以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。